Summary of HIV‑1 vaccine clinical studies conducted by Johnson & Johnson
Study name
Study number
Clinicaltrials.gov identifier
countries
Study name
Mensch
Study number
HIV-V-A002 / IPCAVD006
Clinicaltrials.gov identifier
Countries
USA (single site in Boston)
Study name
Approach
Study number
HIV-V-A004
Clinicaltrials.gov identifier
Countries
RwandaSouth AfricaThailandUgandaUSA
Study number
HPX1002 / IPCAVD010
Clinicaltrials.gov identifier
Countries
USA (single site in Boston)
Study name
Traverse
Study number
HPX2004 / HVTN 117
Clinicaltrials.gov identifier
Countries
RwandaUSA
Study name
Ascent
Study number
HPX2003 / HVTN 118
Clinicaltrials.gov identifier
Countries
KenyaRwandaUSA
Study name
Imbokodo
Study number
HPX2008 / HVTN 705
Clinicaltrials.gov identifier
Countries
MalawiMozambiqueSouth AfricaZambiaZimbabwe
Study name
Mosaico
Study number
HPX3002 / HVTN 706
Clinicaltrials.gov identifier
Countries
ArgentinaBrazilItalyMexicoPeruPolandSpainUSA (including Puerto Rico)
Contact information for the VISP HIV Testing Service for former Johnson & Johnson study participants:
https://myaccessprograms.parexel.com/ords/f?p=177:111*
If you have any further questions, please contact:
*Johnson & Johnson and Parexel are collaborating to provide the VISP HIV Service for former study participants.